Drug Manufacturers – Major Stocks Gained Stunning Volumes: (NYSE:MRK), (NYSE:JNJ), (NYSE:BMY), (NASDAQ:KERX).
Houston, TX – February 8 , 2013 — (Net PR News) – AnotherWinningTrade.com, the leader for breaking information and up-to-date market activities on Wall Street, locates high-growth equity opportunities. To receive our FREE, comprehensive newsletter, visit AnotherWinningTrade.com.
Today’s focus is on: MRK, JNJ, BMY, KERX
Merck & Co., Inc. (NYSE:MRK) has reported that, a highly praised photographer and HIV supporter, Duane Cramer, has intended to join the national HIV education campaign, I Design. Merck & Co., Inc. (NYSE:MRK) traded with volume of 16.17 million shares and its average volume scored lower from day’s volume, as the average trading capability of the stock remained 14.89 million shares. Tracking its trend for the past one month, the stock was a loser as it dropped -2.66%. The three months and six months trends were in the red as it plunged -7.78% and -6.82%, respectively.
Is MRK A Solid Investment At These Levels? Find Out Exactly Where MRK Is Headed With This TREND ANALYSIS REPORT
Johnson & Johnson (NYSE:JNJ) has planned to join the conference of 2013 Leerink Swann Global Health Care, that will be on February 13, 2013 at The Waldorf Astoria in New York. Investors and other interested parties will be able to access the webcast of the event by visiting the JNJ website.
Get A Free Report And Detailed Analysis On JNJ CLICK HERE To Read
Johnson & Johnson (NYSE:JNJ)’s average volume was 9.91 million shares and its Thursday’s volume was 9.80 million shares. Yesterday, JNJ closed the session at $75.06 and remained in the negative as its percentage change was -0.44%.
Bristol Myers Squibb Co. (NYSE:BMY) has planned to participate in the Leerink Swann 2013 Global Health Care Conference on 13th February in New York. Charles Bancroft, executive vice president as well as CFO, will be in a question and answer period about the Company at 3:30 p.m. Eastern Standard Time.
How Should Investors React To BMY Now? Find Out In This TREND ANALYSIS REPORT
The number of shares traded by BMY in yesterday’s trading session was 8.03 million, while average volume was 9.94 million shares.
Keryx Biopharmaceuticals (NASDAQ:KERX) traded with volume of 7,997,600 shares and its average volume remained larger from the day’s volume, as the average trading volume of KERX remained 11.47 million shares. KERX fell -0.59% in the prior session and its closing price was $6.69.
If we track the stock performance for the past 5 days, it reported a bearish figure of -26.32% and its monthly performance was in the green as it advanced +125.25%, this bullish performance is seen in its quarterly period as the company scored+183.47%.
How Should Investors Trade KERX Now? Don’t Trade KERX Until You Read This TREND ANALYSIS REPORT
Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid IO News Wire twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation; do no trading of any kind and send no faxes or emails.